Bio-Rad Laboratories Inc Stock Forecast for 2023 - 2025 - 2030

Updated on 02/28/2024

Stock Rating
16
Price Target
$436.70
Consensus
Outperform
Upside
32.44%
Analysts
1
Stock Rating
16
Upside
32.44%
Analysts
1
Price Target
$436.70

Bio-Rad Laboratories Inc Stock Forecast and Price Target

Year-long price target forecasts from prominent analysts have recently been released for Bio-Rad Laboratories Inc, with an average price target of $436.70. This potential gain of 32.44 percent from the previous closing price in February, 2024 is calculated on a high forecast of $480.00 and a low estimate of $400.00. If you're thinking of investing in BIO stock, it might be good to look at its rivals too.

$436.70

32.44% Upside

Buy
Buy

Bio-Rad Laboratories Inc Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, Bio-Rad Laboratories Inc's Price has decreased from $449.10 to $0.00 – a 100.00% drop! In the next year, analysts predict that Fair Value will reach $508.86 – an increase of 100.00%. For the next nine years, the forecast is for Fair Value to grow by 100.00%.

2024 Fair Value Forecast
$508.86
2024 Fair Value Forecast
$508.86
2025 Fair Value Forecast
$666.82
2025 Fair Value Forecast
$666.82
2026 Fair Value Forecast
$604.49
2027 Fair Value Forecast
$577.53
2028 Fair Value Forecast
$606.37
2029 Fair Value Forecast
$627.03
2030 Fair Value Forecast
$619.96
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
TMO Stock Forecast Thermo Fisher Scientific Outperform 10
$566.17 Buy/Sell $591.94 5.98%
DHR Stock Forecast Danaher Outperform 10
$254.86 Buy/Sell $260.33 2.02%
A Stock Forecast Agilent Technologies Outperform 10
$132.55 Buy/Sell $138.82 5.62%
MTD Stock Forecast Mettler-Toledo International Hold 13
$1.21k Buy/Sell $1.12k -1.09%
ILMN Stock Forecast Illumina Outperform 16
$139.76 Buy/Sell $159.28 7.33%

Bio-Rad Laboratories Inc Revenue Forecast for 2023 - 2025 - 2030

Bio-Rad Laboratories Inc's Revenue has grown in the last three years, jumping from $2.55B to $2.67B – an increase of 4.94%. In the next year, analysts predict that Revenue will reach $2.74B – an increase of 2.50%. For the next eight years, the forecast is for Revenue to grow by 6.90%.

2024 Rev Forecast
$2.74B
2024 Rev Forecast
$2.74B
2025 Rev Forecast
$2.96B
2026 Rev Forecast
$2.86B
2027 Rev Forecast
$2.82B
2028 Rev Forecast
$2.80B
2029 Rev Forecast
$2.85B
2030 Rev Forecast
$2.86B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
WAT Stock Forecast Waters Hold 15
$332.65 Buy/Sell $323.50 -1.85%
AVTR Stock Forecast Avantor Outperform 16
$24.41 Buy/Sell $23.25 12.25%
PKI Stock Forecast PerkinElmer Outperform 16
$105.63 Buy/Sell $121.84 17.28%

Bio-Rad Laboratories Inc Dividend per Share Forecast for 2023 - 2025 - 2030

2024 DPS Forecast
$0.00
2025 DPS Forecast
$0.00
2026 DPS Forecast
$0.00
2027 DPS Forecast
$0.00
2028 DPS Forecast
$0.00
2029 DPS Forecast
$0.00
2030 DPS Forecast
$0.00
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
BRKR Stock Forecast Bruker Outperform 16
$83.70 Buy/Sell $73.64 7.53%
COHR Stock Forecast Coherent - 12
$33.97 Buy/Sell $258.00 -100.00%
PACB Stock Forecast Pacific Biosciences of Califor... Outperform 9
$5.62 Buy/Sell $12.67 69.04%

Bio-Rad Laboratories Inc Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
$0.24B
2025 FCF Forecast
$0.49B
2025 FCF Forecast
$0.49B
2026 FCF Forecast
$0.71B
2027 FCF Forecast
$0.51B
2028 FCF Forecast
$0.52B
2029 FCF Forecast
$0.53B
2030 FCF Forecast
$0.59B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
LAB Stock Forecast Standard BioTools Buy 11
$2.34 Buy/Sell $4.00 70.94%
HBIO Stock Forecast Harvard Bioscience Buy 14
$4.42 Buy/Sell $7.00 58.37%
EQTL Stock Forecast Equitech International - 0
$1.40 Buy/Sell $0.00 -100.00%

Bio-Rad Laboratories Inc EBITDA Forecast for 2023 - 2025 - 2030

In the last three years, Bio-Rad Laboratories Inc's EBITDA has fallen from $546.86M to $483.75M – a 11.54% decrease. In the next year, analysts expect EBITDA to reach $552.79M – an increase of 14.27%. For the next eight years, the forecast is for EBITDA to grow by 26.86%.

2024 EBITDA Forecast
$0.55B
2024 EBITDA Forecast
$0.55B
2025 EBITDA Forecast
$0.69B
2026 EBITDA Forecast
$0.60B
2027 EBITDA Forecast
$0.59B
2028 EBITDA Forecast
$0.58B
2029 EBITDA Forecast
$0.62B
2030 EBITDA Forecast
$0.61B
Ticker Name Consensus Stock Rating Price Buy/Sell Price Target Upside/Downside
ASPT Stock Forecast Haber - 0
$0.00 Buy/Sell $0.00 0.00%
MDIT Stock Forecast Medite Cancer Diagnostics - 0
$0.00 Buy/Sell $0.00 0.00%
OMRX Stock Forecast Orthometrix - 0
$0.00 Buy/Sell $0.00 0.00%

Bio-Rad Laboratories Inc EBIT Forecast for 2023 - 2025 - 2030

Bio-Rad Laboratories Inc's EBIT has decreased In the last three years, from $408.76M to $337.80M – a 17.36% drop. The next year looks promising for Bio-Rad Laboratories Inc, with analysts predicting EBIT of $410.68M – an increase of 21.57%. Over the next eight years, experts anticipate that Bio-Rad Laboratories Inc's EBIT will grow at a rate of 44.13%.

2024 EBIT Forecast
$0.41B
2025 EBIT Forecast
$0.54B
2025 EBIT Forecast
$0.54B
2026 EBIT Forecast
$0.46B
2027 EBIT Forecast
$0.45B
2028 EBIT Forecast
$0.48B
2029 EBIT Forecast
$0.50B
2030 EBIT Forecast
$0.49B

Bio-Rad Laboratories Inc EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, Bio-Rad Laboratories Inc's EPS has decreased from $10.52 to $0.00 – a 100.00% drop! In the next year, analysts predict that EPS will reach $11.92 – an increase of 100.00%. For the next nine years, the forecast is for EPS to grow by 100.00%.

2024 EPS Forecast
$11.92
2024 EPS Forecast
$11.92
2025 EPS Forecast
$15.62
2025 EPS Forecast
$15.62
2026 EPS Forecast
$14.16
2027 EPS Forecast
$13.53
2028 EPS Forecast
$14.20
2029 EPS Forecast
$14.69
2030 EPS Forecast
$14.52